Introduction {#s001}
============

T[ick-borne encephalitis virus]{.smallcaps} (TBEV) is a human-pathogenic arbovirus transmitted by ixodid ticks and a member of the genus *Flavivirus* within the family *Flaviviridae* (Simmonds et al. [@B30]). Tick-borne encephalitis (TBE), caused by the flavivirus, is endemic in most of the European countries, Russia, northern parts of China, and Japan. During the past few decades endemic areas have expanded and within many endemic areas the number of reported cases increased (Bogovic and Strle [@B5]). TBE has an important impact on public health---the incidence of clinical cases is reported to be between 10,000 and 15,000 per year worldwide, although it is very probably underestimated, because notification of the disease is not mandatory in all countries (Amicizia et al. [@B3]).

The established method of TBEV genotyping has been based on envelope (E) protein gene structure (Ecker et al. [@B12]), while subtype-specific sites are also located in all virus genes (Pogodina et al. [@B23], Zlobin et al. [@B36], Verkhozina et al. [@B34]). Now three TBEV subtypes are distinguished---the European/Western subtype (TBEV-Eu), the Far Eastern (TBEV-FE), and the Siberian subtype (TBEV-Sib) (Ecker et al. [@B12], Zlobin et al. [@B36], Simmonds et al. [@B30]). In addition, two other potential subtypes have been identified in a few instances. The fourth subtype represents only one isolate (178-79 TBE isolate), originated from Irkutsk region, Russia, and preliminary typed as TBEV-FE. The fifth subtype includes 10 isolates, originated from Buryatia, Chita, and Irkutsk regions, Russia (886-84 isolate preliminary typed as TBEV-Sib) (Verkhozina et al. [@B34], Demina et al. [@B10]).

A clear association of TBE pathogenesis has been demonstrated with TBEV subtype, as well as geographical location (Charrel et al. [@B7]). Indeed, subtypes are associated with a particular clinical presentation, including variable case fatality rate, chronic forms, or neurological involvement (Dumpis et al. [@B11], Gratz [@B16]). In addition, ticks harbor epidemiological pattern of TBE, which appears closely related to the ecology and biology of the main tick vector species, including *Ixodes persulcatus* (TBEV-Sib; TBEV-FE), *I. ricinus* (TBEV-Eu) with respect to their distribution, seasonality, and tick feeding habit (Dumpis et al. [@B11], Ecker et al. [@B12], Randolph et al. [@B25]). Ultimately, each of three subtypes predominates within a particular area, where concurrently other subtypes can cocirculate (Süss et al. [@B31], Zlobin et al. [@B36]).

To date, from the limited virus isolates done in Ukraine, there is evidence that all TBEV subtypes---TBEV-FE (Ecker et al. [@B12]), TBEV-Eu (Iurchenko et al. [@B18]), and TBEV-Sib (Kozlova et al., personal communication; GenBank data) are present on the Crimean peninsula, and TBEV-Sib can be found in the northwestern region of the country (Volyn Oblast) (Adel\'shin et al. [@B1]).

The aim of the present work was to investigate TBEV genetic variability in southern Ukraine and to identify any genetically determined changes within the E protein of virus isolates. In this article, for a better understanding of TBEV ecology and epidemiology in the country, we will present the characterization of the TBEV isolates from the study sites and a comparison to all TBEV E protein gene sequences available from Ukraine.

Methods {#s002}
=======

Tick collection {#s003}
---------------

Tick collection was done across 15 sites among 5 administrative territories of southern Ukraine, including Odessa, Mykolaiv, Kherson Oblast, the Autonomous Republic of Crimea, and Sevastopol, and performed predominantly in a spring season (May--September 1988; March--June 1989; March--June, September 1990) from three consecutive years 1988 to 1990 using either flagging technique (free ticks) or direct tick collection from cattle (feeding stage) ([Fig. 1](#f1){ref-type="fig"}, blue and purple dots). Ticks were identified by morphotaxonomy, transported to the laboratory, and stored alive in humid chambers or in tubes immersed into liquid nitrogen before testing.

![Identified sites where tick-borne encephalitis virus has been isolated in Ukraine. See [Supplementary Table S2](#SD1){ref-type="supplementary-material"} for virus strain characteristics. Credit: Dr. Marc Souris, Laos and Cambodia representative, Institute of Research for Development (IRD-UMR 190).](fig-1){#f1}

The sites sampled for ticks, and identified sites where TBEV has been isolated, were mapped using the SavGIS 9.07.007 software (SavGIS, [@B29]).

Virus isolation and identification {#s004}
----------------------------------

Virus isolation was conducted in the same year the ticks were collected and identified. For virus isolation ticks were pooled approximately till 50 imagoes and 200 nymphs of one species were collected in one site at the same time. Pooled ticks were washed once with ethanol and then two to three times with Hanks\' balanced salt solution pH 7.2. Then ticks were ground with quartz sand by a pestle in a porcelain mortar in a sterile environment and added 2--4 mL of medium 199 pH 7.2 with 10% fetal calf serum and antibiotics (100 units per 1 mL). The obtained suspensions were centrifuged at 1500 *g* at 4°C for 15 min, and the supernatants were used for the intracerebral inoculation of 1- to 3-day-old (newborn) white mice (0.01--0.02 mL per mouse) as described earlier (Gould and Clegg [@B15]). The mice were observed for 3 weeks. With the development of symptoms (anorexia, inactivity, paralysis, and paresis) sick mice were euthanized and their brains were used for subsequent passaging. The 10% brain homogenates on the medium 199 pH 7.2 were prepared, centrifuged at 1500 *g* at 4°C for 15 min, filtered through 220 nm pore diameter syringe filters (Millipore) to eliminate the bacteria, and used for intracerebral inoculation of newborn mice. TBEV isolates were stored frozen with the periodical passaging through newborn mice brain.

Virus identification was done in complement fixation test (CFT) according to the standard procedure (Casey [@B6]). For CFT viral sucrose-acetone antigens (Clarke and Casals [@B8]) and mouse hyperimmune ascitic fluids (Tikasingh et al. [@B33]) were produced. The reference antigens and immune sera were provided by D.I. Ivanovsky Institute of Virology.

TBEV prevalence calculation {#s005}
---------------------------

Calculation of TBEV prevalence in ticks was done using the minimum infection rate (MIR) as a method for estimating infection rates from pooled sampling when the prevalence is extremely low (\<0.1%) as described elsewhere (Cowling et al. [@B9]) and eventually applied for TBEV prevalence by others (Andreassen et al. [@B4]). MIR calculation was done using the following formula with the assumption that each positive pool is infected by a single individual: $$\documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\usepackage{upgreek}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}
\begin{align*}
{ \rm{MIR}} = ( {{ \rm{x}} / ( {{ \rm{mk}}} ) } ) 100 \% ,
\end{align*}
\end{document}$$

where:

k = pool size,

m = the number of pools tested,

x = the number of positive pools.

The MIR values are expressed as percentage of potentially infected ticks in a given population at a given time.

The confidence intervals were estimated by calculating the corresponding binomial confidence limits (P) using the formula, which is applicable when the estimated prevalence ≤25% and ≥75% and expressed as percentage (Lakin [@B21]): $$\documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\usepackage{upgreek}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}
\begin{align*}
 { \rm { P = } } \frac { 1 }  { { { \rm { mk + } } { { \rm { t }
} ^2 } } } \left[ \left( { \rm { x } } + \frac { { { { \rm { t } }
^2 } } }  { 2 } \right) \pm { \rm { t } } \sqrt { { \frac { { \rm
{ x } } ( { \rm { mk  -  x } } ) }  { { \rm { mk } } } } + } \frac
{ { { { \rm { t } } ^2 } } }  { 4 } \right] ,
\end{align*}
\end{document}$$

where symbols are corresponded to the MIR formula.

Sequencing {#s006}
----------

Sanger technique was used for the nucleotide sequencing (Sanger et al. [@B28]). TBEV RNA was extracted from mice brain tissue containing virus. The isolate history varied from 7 to 13 passages. Isolation of total RNA was performed using a set of TRIzol^®^ Plus RNA Purification Kit Reagent (Invitrogen, USA). Complementary DNA (cDNA) was synthesized with High Capacity cDNA Reverse Transcription Kit with RNase Inhibitor (Applied Biosystems, USA) and random primers. Amplification of three overlapping fragments of the E protein gene was performed in the reaction mixture Platinum PCR SuperMix (Invitrogen) with the oligonucleotide primers developed with the Primer3 software (Rozen et al. [@B27]), available on the website <http://frodo.wi.mit.edu/primer3/and> published earlier (Iurchenko et al. [@B18]). The PCR products were purified with NucleoSpin Extract II Kit (Macherey-Nagel, Germany), amplified in a reaction mixture with terminators (BigDye Terminator v3.1 Cycle Sequencing Kit; Applied Biosystems) with the same primers (Iurchenko et al. [@B18]). After purification on NucleoSEQ columns (Macherey-Nagel) the products of PCR with terminators were analyzed by the capillary electrophoresis in automatic Applied Biosystems 3130 Genetic Analyzer. All stages of the sequencing were conducted in accordance with reagent\'s manufacturer instructions.

Sequencing alignment and assembly of the consensus sequences of E protein gene were done using the BioEdit version 7.0.5.3 software (Hall [@B17]).

Phylogenetic analysis {#s007}
---------------------

Phylogenetic analysis was carried out using the software MEGA7 (Kumar et al. [@B20]). To determine evolutionary distance and genetic relationships of TBEV isolates, the complete E protein gene analysis was performed and applied to 111 TBEV strain nucleotide sequences available in GenBank database and seven TBEV isolate sequences, including the four present and three others already published (Iurchenko et al. [@B18]) ([Supplementary Tables S2](#SD1){ref-type="supplementary-material"} and [S3](#SD2){ref-type="supplementary-material"}). Spanish sheep encephalitis (X77470.1), louping ill (M94957.1), Negishi (M94956.1), Greek goat encephalitis (X77732.1), Turkish sheep encephalitis (DQ235151.1), Omsk hemorrhagic fever (X66694.1), Langat (DQ845244.1), and Kyasanur forest disease (X74111.1) viruses of mammalian tick-borne virus group were used as the out-group.

To illustrate that all three TBEV subtypes are circulating in Ukraine, the phylogenetic tree was generated and applied to all available 12 nucleotide sequences (complete and partial) of the E protein gene of TBEV isolated in Ukraine and three reference isolates belonging to three different subtypes ([Supplementary Tables S2](#SD1){ref-type="supplementary-material"} and [S3](#SD2){ref-type="supplementary-material"}).

The reliability of the phylogenetic trees was tested by bootstrap resampling (1000 replications).

TBEV E protein analysis {#s008}
-----------------------

Jalview 2.9.0b2 software was used to align TBEV E protein amino acid sequences and discover marker amino acid substitutions (Waterhouse et al. [@B35]).

Availability of data and materials {#s009}
----------------------------------

The datasets supporting the conclusions of this article are included within the article and its supplementary files.

Results {#s010}
=======

TBEV prevalence and isolate characteristics {#s011}
-------------------------------------------

Collection sites were originally selected within the All-Union Program on Arbovirus Surveillance led by the Ivanovsky Institute of Virology (Moscow, Russia). In addition, TBEV strains from sporadic registered cases in Crimea were used. A total of 15,243 tick imagoes and nymphs were collected from nine tick species, including *Dermacentor marginatus*, *D. reticulatus*, *Haemaphysalis parva*, *H. punctata*, *I. ricinus*, *Hyalomma marginatum*, *Rhipicephalus bursa*, *R. rossicus*, and *R. sanguineus*, pooled in 282 monospecific samples for virus isolation by intracerebral inoculation of newborn mice.

Eight TBEV isolates were from ticks collected at 6 of the 15 sites of three administrative territories ([Fig. 1](#f1){ref-type="fig"}). In one site (Byriuchyj Island, Heniches\'k District, Kherson Oblast) TBEV was detected for two consecutive years showing the temporal persistence of the pathogen ([Table 1](#T1){ref-type="table"}; [Supplementary Table S1](#SD3){ref-type="supplementary-material"}; Supplementary Data are available online at [www.liebertpub.com/vbz](www.liebertpub.com/vbz)). An estimated TBEV pooled tick prevalence using the MIR was recorded from 0.11% to 0.81% among positive sites and 95% upper confidence limit did not exceed 4.49% ([Table 1](#T1){ref-type="table"}).

###### 

[Tick-Borne Encephalitis Virus Estimated Pooled Prevalence as Minimum Infection Rate and 95% Confidence Interval Among Ixodid Ticks in the Positive Sites of Southern Ukraine, 1988--1990]{.smallcaps}

  *District*     *Year*   *Positive pools/pools tested*   *Pool average size*   *MIR (95% CI), %*
  -------------- -------- ------------------------------- --------------------- -------------------
  Kiliia         1988     1/3                             43                    0.77 (0.13--4.28)
  Savran         1989     1/6                             44                    0.38 (0.07--2.13)
  Bakhchysarai   1989     1/6                             95                    0.17 (0.03--0.98)
  Simferopol     1989     1/4                             31                    0.81 (0.14--4.49)
  Henichesk      1989     2/10                            37                    0.54 (0.15--1.95)
                 1990     1/5                             48                    0.41 (0.07--2.33)
  Bilohirsk      1990     1/10                            90                    0.11 (0.02--0.62)

CI, confidence interval; MIR, minimum infection rate.

Phylogenetic analysis {#s012}
---------------------

Nucleotide sequences used for analysis included the one produced by the present study, as well as the sequences obtained from GenBank or other sources of the literature. All sequence origins are listed in detail in the [Supplementary Table S2](#SD1){ref-type="supplementary-material"}. The complete E protein gene nucleotide sequences of seven of the eight TBEV isolates from ixodid ticks in Autonomous Republic of Crimea, Odessa, and Kherson Oblasts from 1988 to 1990 were used for a phylogenetic analysis with 111 TBEV strains available from GenBank ([Supplementary Tables S2](#SD1){ref-type="supplementary-material"} and [S3](#SD2){ref-type="supplementary-material"}). Comparative analysis revealed a 100% identity of the E protein gene sequence among all isolates studied (isolates 120, 150, 70, 80, 85, 290, and Savran 160). Calculation of genetic or evolutionary distances showed a high level of identity of the study isolates with TBEV-Eu, including a nucleotide sequence identity from 93.38% with strain ZH RuetiZH (*I. ricinus* ticks, Switzerland, 2009) (Gäumann et al. [@B13]) to 97.17% with strain Pan (human blood, Russia, 1957) (Ecker et al. [@B12]), compared to a nucleotide sequence identity with TBEV-Sib and TBEV-FE subtypes ranging from 81.72% (isolate Crimea, *I. ricinus* ticks, Ukraine, 1987) to 82.59% (Vasilchenko isolate from human blood, Russia, 1969). The study isolates showed 80.32% of identity with a fourth subtype (*i.e.*, isolate 178-79, I. persulcatus ticks, Russia, 1986) and 83.08% with a fifth subtype (*i.e.*, isolate 886-84, *Myodes rufocanus* rodent, Russia, 1984) (Demina et al. [@B10]). These findings confirmed that all seven isolates from ticks of southern Ukraine belong to the European subtype showing a maximum identity of 97.17% to the "Pan TBEV-Eu" reference strain and clustering together in the same clade, distinguishing itself from other TBEV-Eu strains ([Fig. 2](#f2){ref-type="fig"}; [Supplementary Fig. S1](#SD4){ref-type="supplementary-material"}).

![Phylogenetic tree construction (MEGA 7 software) based on the nucleotide sequence of the E protein gene illustrating the presence of all three TBEV subtypes in Ukraine. E gene nucleotide sequences were aligned with Muscle and analyzed by Maximum Likelihood method. The reliability of the tree was tested by bootstrap resampling (1000 replications). In addition, comparison of the Ukrainian strains with other TBEV-Eu strains isolated in Europe and Asia is presented in the [Supplementary Figure S1A and B](#SD4){ref-type="supplementary-material"}. \*Reference strain subtype. E, envelope; TBEV, tick-borne encephalitis virus.](fig-2){#f2}

Phylogenetic analysis of all available E protein gene nucleotide sequences (complete and partial) of the 12 TBEV isolates in Ukraine, as well as three reference strains belonging to different subtypes ([Supplementary Tables S2](#SD1){ref-type="supplementary-material"} and [S3](#SD2){ref-type="supplementary-material"}), indicated that all three TBEV subtypes were present in Ukraine ([Fig. 2](#f2){ref-type="fig"}). Ultimately, the current study confirmed the presence of TBEV-Eu in southern Ukraine that overlapped a same territory as TBEV-FE and TBEV-Sib showing the heterogeneity of TBEV cocirculating on the Crimean peninsula ([Fig. 2](#f2){ref-type="fig"}).

E protein characterization {#s013}
--------------------------

Altogether, TBEV isolates 120, 150, 70, 80, 85, 290 and Savran 160 were clearly identified to be of TBEV-Eu subtype with respect to their dedicated amino acid signature---47(A), 88(G), 115(A), 178(E), 206(V), 267(A), 277(E), 317(A), 426(A), 431(S), 433(I), and 437(V), which appears entirely contained among all of the seven isolates and specific to TBEV-Eu type as previously described (Ecker et al. [@B12]).

Amino acid sequence analysis of all TBEV-Eu South Ukrainian isolates showed consistent presence of four marker amino acid substitutions, including 67(N), 266(R), 306(V), and 407(R) ([Table 2](#T2){ref-type="table"}). The 67(N) appears unique in South Ukrainian isolates, while all other known TBEV isolates, regardless of the subtype, have aspartic acid (D) at position 67. Arginine (R) at position 266 was previously identified only in two isolates from *I. ricinus* ticks in Switzerland in 2009---ZH Langnau a.A.1 and ZH Langnau a.A.2 (Gäumann et al. [@B14]), while all other TBEV strains have lysine (K) at position 266. Besides South Ukrainian isolates, valine (V) at position 306 was found only in five isolates: TBEV-Eu Pan, ZZ9 (*I. ricinus* ticks, Austria, 1985) (Ecker et al. [@B12]), VD Cudrefin (*I. ricinus* ticks, Switzerland, 2009) (Gäumann et al. [@B13]), and TBEV-FE strains Oshima 5-10 isolates (human, Japan, 1993) (Takashima et al. [@B32]) and 178-79 isolates. All other known isolates have methionine (M) at the position 306. Arginine (R) at position 407 detected in South Ukrainian isolates is typical for the TBEV-Sib and TBEV-FE (including Crimea isolate) subtypes and was revealed only in two TBEV-Eu strains---Pan and Stara Ves (Croatia) (Ecker et al. [@B12]).

###### 

[Marker Amino Acid Substitutions in the Envelope Protein of Tick-Borne Encephalitis Virus Strains Isolated in Southern Ukraine Compared with the Prototype Strains]{.smallcaps}

                                                                   *Amino acid substitutions*                                               
  ------------- -------------------------------------------------- ---------------------------- ---- ---- ---- ---- ------- ------- ------- ----
  European      **120**^[**b**](#tf2){ref-type="table-fn"}^        P                            A    N    G    A    **R**   **V**   **R**   V
                ZH Langnau a.A.1^[c](#tf2){ref-type="table-fn"}^   P                            A    D    G    A    **R**   M       K       V
                ZZ9^[d](#tf2){ref-type="table-fn"}^                P                            A    D    G    A    K       **V**   K       V
                Pan^[e](#tf2){ref-type="table-fn"}^                P                            A    D    G    A    K       **V**   **R**   V
                Neudoerfl                                          P                            A    D    G    A    K       M       K       V
  Siberian      **Crimea-2**^[**f**](#tf2){ref-type="table-fn"}^   --                           --   --   --   --   --      --      --      I
                **Semeks**                                         --                           P    --   S    --   --      --      --      --
                Zausaev                                            P                            A    D    G    A    K       M       R       V
                886-84                                             P                            A    D    G    A    K       M       R       V
                Buzuuchuk                                          P                            A    D    G    A    K       M       R       V
                Vasilchenko                                        P                            A    D    G    A    K       M       R       V
  Far Eastern   **Crimea**                                         L                            A    D    G    V    K       M       R       V
                Sofjin                                             P                            A    D    G    A    K       M       R       V
                Oshima 5-10^[g](#tf2){ref-type="table-fn"}^        P                            A    D    G    A    K       **V**   R       V

Position numbers are counted from the first amino acid of Envelope protein. The names of the strains isolated in Ukraine are highlighted in *bold*. The unique amino acid substitutions highlighted in *black*, the rare ones in TBEV in *gray*, and the rare ones in this subtype and typical for others framed with *black line square*. In the table one of the strains represents a group with identical amino acid substitutions in the selected positions: ^b^strains 120, 150, 70, 80, 85, 290 and Savran 160; ^c^strains ZH Langnau a.A.1 and ZH Langnau a.A.2; ^d^strains ZZ9 and VD Cudrefin; ^e^strains Pan and Stara Ves; ^f^strains Crimea-2, Crimea-8 and Crimea-10; ^g^strains Oshima 5--10 and 178--79.

TBEV, tick-borne encephalitis virus.

Two of the amino acid substitutions revealed in the South Ukrainian TBEV isolates, 67(N) and 266(R), are located in the domain II (amino acid residues 52-136 and 190-284), the 306(V) in the domain III (amino acid residues 303-395) (Rey et al. [@B26]), and 407(R) in the stem-anchor region (residues 401-496) (Allison et al., [@B2]) ([Table 2](#T2){ref-type="table"}).

Furthermore, the unique amino acid substitutions were found in other TBEV isolates in Ukraine. TBEV-FE strain Crimea has amino acid substitutions 39(L) in the domain I (residues 1-51, 137-189, and 285-302) (Rey et al. [@B26]) and 246(V) in the domain II. Both substitutions are not found in TBEV, but valine (V) at position 246 is a typical for 2 other flaviviruses---Omsk hemorrhagic fever and Negishi (results not showed). Crimea-2, Crimea-8 and Crimea-10 isolates are distinguished from all other TBEV isolates by the presence of isoleucine (I) at position 487 in the stem-anchor region, while all other TBEV isolates have valine (V) at the position. Volhynian isolate Semeks has unique amino acid substitutions 189(P) and 100(S) located in the domain I and the domain II correspondingly ([Table 2](#T2){ref-type="table"}).

Discussion {#s014}
==========

With respect to the TBEV activity in Ukraine and its vectors, the virological testing revealed the presence of TBEV among ixodid ticks in southern Ukraine, in 1988--1990. TBEV estimated pooled prevalence of ticks in the region varied from 0.11% to 0.81%. These findings are consistent with the results of the virological examination of ixodid ticks on the Crimean peninsula in 1985--1990, when 63 isolates were recovered from 35,170 ticks, when the average MIR of ticks with TBEV was 0.18% (Markeshin [@B22]) \[where the infection prevalence of TBEV in unfed host-questing ticks is typically 0.1--5.0%, with some exceptions in Far East Russia (Randolph [@B24])\], is also consistent with the current study\'s findings.

TBEV was detected in *I. ricinus* tick---the main vector of TBEV-Eu (Dumpis et al. [@B11], Ecker et al. [@B12], Randolph et al. [@B25]) and also among ticks of three other species indicating a consistent virus presence in the study area through the identified vector hosts.

Phylogenetic analysis of seven of the eight TBEV isolates from southern Ukraine showed 100% identity of the E protein gene nucleotide sequences in all isolates studied and their belonging to European/Western subtype. Moreover, these isolates form a separate phylogenetic cluster inside TBEV-Eu subtype with Pan strain. Ultimately, one hypothesis is that TBEV-Eu strains isolated in southern Ukraine were evolving independently of the rest of TBEV-Eu strains and diverged from a common ancestor with the Pan strain after differentiation of TBEV-Eu strains into two clusters ([Supplementary Fig. S1](#SD4){ref-type="supplementary-material"}).

We observed several original structural protein gene mutations (*i.e.*, amino acid substitutions) that eventually provide more insight for the understanding of their significance in terms of functionality, as well as TBEV circulation in Ukraine. Indeed, analysis of dedicated amino acid sequences of E protein revealed the presence of four amino acid substitutions that distinguished TBEV-Eu strains isolated in the current study region (120, 150, 70, 80, 85, 290, and Savran 160) from the other known isolates. Furthermore, unique amino acid substitutions in the E protein were revealed in TBEV-FE (Crimea isolate) and TBEV-Sib (isolates Semeks, Crimea-2, Crimea-8 and Crimea-10 isolates) in Ukraine by other researchers (Ecker et al. [@B12], Adel\'shin et al. [@B1], Kozlova et al., personal communication; GenBank data). The biological role of amino acid substitutions so far has not been totally elucidated; however, it is known that all domains of the ectodomain possess antigenic activity and can determine the virulence for different isolates. Furthermore, the domain II is presumably participating in the virus fusion with a cell membrane, and the domain III is a potential binding site of a cellular receptor (Rey et al. [@B26]). The stem-anchor region of the E protein is important for a number of functions, including trimerization of soluble protein E, interactions with the precursor of membrane protein M during viral assembly, particle formation, and low-pH-induced structural changes associated with membrane fusion (Allison et al. [@B2]). Ultimately, the presence of the unique and rare amino acid substitutions in the Ukrainian TBEV isolates distinguished them from the isolates circulating in other territories. Further molecular-genetic studies are necessary to conclude if these substitutions serve as markers of the regional TBEV population in Ukraine.

However, the E protein gene sequence analyzed is associated with specific TBEV isolates recovered from different origins and could eventually be subject to genetic variations introduced by host-virus interactions during repeated passaging through newborn mice brain cells. In addition, cross-contamination cannot be excluded in the process of long-term maintenance. Although E protein gene data allowed defining a subtype of TBEV isolated in southern Ukraine from 1988 to 1990, whole genome sequencing could provide new knowledge about the genetic variability of TBEV population. Such an approach is indeed of great importance for the understanding of the origin and evolution of the virus, as well as the formation and maintenance of TBE natural foci (Kovalev and Mukhacheva [@B19]). In addition, genotyping circulating virus strains should be useful for epidemiological surveillance, as well as improving diagnostic and prophylaxis of the disease in Ukraine.

Conclusion {#s015}
==========

This study confirmed the occurrence of European subtype of TBEV in southern Ukraine. A comparative phylogenetic analysis of the E protein gene showed the homogeneity of European subtype TBEV population in Ukraine, while the seven isolates from southern Ukraine are most related to Pan strain and form with it a separate phylogenetic cluster within TBEV-Eu subtype. At the same time, concurrent circulation of two other subtypes, including TBEV-Sib and TBEV-FE in Crimean peninsula, is showing the heterogeneity of TBEV population in the region. Because it has been nearly 30 years since the sampling, we referred to, was carried out, the epidemiology could have changed, and further studies are needed to evaluate the risk of TBEV expansion and therefore identify driving forces for TBEV and ticks\' geographical range.
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